The longer the bootcamp, the better the antibodies
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) have discovered how the immune system can transform into an
New vaccine ingredient shows promise
Most vaccines include particles called adjuvants. But not all adjuvants are created equal.
Six LJI scientists named “Highly Cited Researchers”
The international recognition reflects how LJI research is valued by scientific peers
LJI graduate students win prestigious ARCS San Diego awards
ARCS support propels vaccine design and HIV research
Inside the labs of three leading San Diego scientists
LA JOLLA—Studying the immune system means venturing into uncharted territory, leading explorations of the countless immune cells and genetic players
Beating HIV and COVID-19 may depend on tweaking vaccine molecules
LA JOLLA—Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune
HIV Vaccine Research (AIDS Vaccine Research)
Broadly neutralizing antibodies have been discovered in ~5% of HIV+ individuals. Some of those antibodies (HIV bnAbs) are capable of
Designing Vaccines: Differentiation and Function of Follicular Helper CD4 T Cells (Tfh Cells)
A video lecture on Tfh cell biology can be seen here. Germinal centers are the critical sites for the development
Crotty Lab
Shane Crotty,
Ph.D.
Professor
Center for Infectious Disease and Vaccine Research
Shane Crotty, Ph.D., and his team study immunity against infectious diseases. They investigate how the immune system remembers infections and vaccines.
Groundbreaking HIV vaccine design strategy shows promise in proof-of-principle tests
LA JOLLA, CA – A collaborative team of scientists has made a successful proof-of-principle demonstration of an advanced HIV vaccine
Dr. Shane Crotty honored with 2019 Frederick W. Alt Award for New Discoveries in Immunology
LA JOLLA, CA—Shane Crotty, Ph.D., a professor at La Jolla Institute for Immunology, has been selected to receive the 2019
New HIV vaccine strategy “pumps” the immune system
LA JOLLA, CA – A new HIV vaccine delivery strategy appears to enhance the protective immune response in a preclinical